About N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide
N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide (PubChem CID 25039593) has the molecular formula C16H18BrN5O3S3
and a molecular weight of 504.46 g/mol. Its IUPAC name is N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide.
Molecular Properties
| Compound Name | N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide |
| PubChem CID | 25039593 |
| Molecular Formula | C16H18BrN5O3S3 |
| Molecular Weight | 504.46 g/mol |
| Exact Mass | 502.98 |
| IUPAC Name | N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide |
| SMILES | CCCCn1c(SCC(=O)Nc2ncc(Br)s2)nc2cc(S(N)(=O)=O)ccc21 |
| InChI | InChI=1S/C16H18BrN5O3S3/c1-2-3-6-22-12-5-4-10(28(18,24)25)7-11(12)20-16(22)26-9-14(23)21-15-19-8-13(17)27-15/h4-5,7-8H,2-3,6,9H2,1H3,(H2,18,24,25)(H,19,21,23) |
| InChIKey | BQBZARVREOYTNB-UHFFFAOYSA-N |
| XLogP | 3.43 |
| TPSA | 119.97 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 504.46 |
| LogP ≤ 5 | 3.43 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide?
The IUPAC name of N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide (CID 25039593) is N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide.
What is the SMILES notation for N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide?
The canonical SMILES for N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide is CCCCn1c(SCC(=O)Nc2ncc(Br)s2)nc2cc(S(N)(=O)=O)ccc21.
What is the InChIKey of N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide?
The InChIKey is BQBZARVREOYTNB-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H18BrN5O3S3/c1-2-3-6-22-12-5-4-10(28(18,24)25)7-11(12)20-16(22)26-9-14(23)21-15-19-8-13(17)27-15/h4-5,7-8H,2-3,6,9H2,1H3,(H2,18,24,25)(H,19,21,23).
What are the key properties of N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide?
N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide has a molecular weight of 504.46 g/mol, XLogP of 3.43, 8 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-bromo-1,3-thiazol-2-yl)-2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanylacetamide is sourced from PubChem (CID 25039593), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).